RESUMO
We studied the B-1 lymphocyte involvement in host reactions to parasites in the murine model of schistosomiasis. No modifications were observed in the prepostural phase of the disease. From the acute phase on, we observed sequentially an increase of Mac1- B-1 cells in the spleen, followed by their appearance in Peyer's patches and in mesenteric ganglia, suggesting that a fraction of splenic B-1 cells might follow this pathway of migration, acquiring progressively the Mac1 expression. These results are consistent with a primary activation of the splenic B cell compartment, with the subsequent mobilization of B-1 cells into the tissue involved by parasites. Conversely, we found no evidence of an increase of B-1 cells in the peritoneum, nor a mobilization of B-1 cells expressing the peritoneal phenotype (CD5lo, IgMhi) into the tissues involved by infection, despite the general inflammatory reactivity of peritoneal cells. In schistosomiasis, the peritoneal cavity B-1 cells on one side, and those involved in inflammatory reactions to parasites in the spleen, Peyer's patches, and mesenteric ganglia on the other, represent two distinct B-1 lymphocyte pools.
Assuntos
Subpopulações de Linfócitos B/imunologia , Esquistossomose mansoni/imunologia , Animais , Antígenos CD5/análise , Feminino , Gânglios Simpáticos/imunologia , Imunoglobulina M/análise , Linfonodos/imunologia , Contagem de Linfócitos , Masculino , Mesentério/inervação , Camundongos , Camundongos Endogâmicos C3H , Cavidade Peritoneal/citologia , Nódulos Linfáticos Agregados/imunologia , Receptores de Antígenos de Linfócitos B/análise , Baço/imunologiaRESUMO
Murine syngeneic mixed leukocyte reaction (SMLR) was studied under totally autologous culture conditions using syngeneic normal mouse serum in the culture. SMLR was detected in splenic, but not in lymph node, nonadherent responding cell populations (NWNAC). In the absence of stimulator, accessory cells (AC), IL3-containing fluids also induced splenic, but not lymph node, NWNAC growth. SMLR-derived supernatants contained IL3, but not IL2, activity, and production of this IL3 activity could be prevented by adding anti-CD4 mAbs to SMLR cultures. Precursor frequencies of both SMLR and IL3 splenic responses were very low and similar, and there was a synergism between IL3 and AC in induction of NWNAC growth. Growth of responding NWNAC was further enhanced by T-cell depletion with anti-Thy1 mAb and complement. Lack of T-cell proliferation in the SMLR was confirmed by BUdR and light protection experiments. Autoradiographs indicated that the same cell type grew in both SMLR and IL3-induced NWNAC cultures. Besides blast cells, cells with the appearance of immature monocytes with 3H-labeled nuclei were found in both kinds of culture. No labeled lymphocytes could be found. Both SMLR and IL3-induced NWNAC cultures contained expanded numbers of M-CSF-responsive monocyte precursors. On the other hand, SMLR- but not IL3-induced cultures contained expanded numbers of IL3-responsive, immature precursors capable of giving rise to large colonies of monocytic-like cells. Although IL2 could not be detected in SMLR supernatants, both cell growth and IL3 production could be blocked with anti-IL2 receptor and anti-IL2 mAbs. Exogenous IL2, on the other hand, enhanced both cell growth and IL3 production in the SMLR. These results indicate that, under totally autologous conditions, CD4+ autoreactive T-cells do not proliferate in the SMLR, but rather instruct the growth of splenic hematopoietic precursors capable of differentiating along the monocytic lineage. Autoreactive T-cell activation in the SMLR seems to involve minimal IL2 production, which is critically necessary for triggering IL3 production in a markedly amplified manner. These results suggest a link between normal regulation of hematopoiesis and MHC-restricted, autoreactive T-cell activation.